CN115025024A - Acne and acne mark removing composition and application thereof - Google Patents
Acne and acne mark removing composition and application thereof Download PDFInfo
- Publication number
- CN115025024A CN115025024A CN202210906071.2A CN202210906071A CN115025024A CN 115025024 A CN115025024 A CN 115025024A CN 202210906071 A CN202210906071 A CN 202210906071A CN 115025024 A CN115025024 A CN 115025024A
- Authority
- CN
- China
- Prior art keywords
- acne
- composition
- extract
- root
- mark
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010000496 acne Diseases 0.000 title claims abstract description 221
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 218
- 239000000203 mixture Substances 0.000 title claims abstract description 102
- 239000000284 extract Substances 0.000 claims abstract description 70
- 239000006071 cream Substances 0.000 claims abstract description 29
- 241000972673 Phellodendron amurense Species 0.000 claims abstract description 11
- 241001506047 Tremella Species 0.000 claims abstract description 11
- 239000002904 solvent Substances 0.000 claims abstract description 11
- 240000002657 Thymus vulgaris Species 0.000 claims abstract description 10
- 235000007303 Thymus vulgaris Nutrition 0.000 claims abstract description 10
- 239000001585 thymus vulgaris Substances 0.000 claims abstract description 10
- 240000006053 Garcinia mangostana Species 0.000 claims abstract description 9
- 235000017048 Garcinia mangostana Nutrition 0.000 claims abstract description 9
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 8
- 240000004534 Scutellaria baicalensis Species 0.000 claims abstract description 5
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 244000146462 Centella asiatica Species 0.000 claims abstract description 4
- 235000004032 Centella asiatica Nutrition 0.000 claims abstract description 4
- 241000246044 Sophora flavescens Species 0.000 claims abstract description 4
- 241001278898 Glycyrrhiza inflata Species 0.000 claims abstract description 3
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 3
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical class OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 30
- 239000003906 humectant Substances 0.000 claims description 28
- 238000002360 preparation method Methods 0.000 claims description 28
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 24
- 238000003756 stirring Methods 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 16
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 15
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 15
- 239000000811 xylitol Substances 0.000 claims description 15
- 235000010447 xylitol Nutrition 0.000 claims description 15
- 229960002675 xylitol Drugs 0.000 claims description 15
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 10
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 9
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 claims description 8
- 229940100524 ethylhexylglycerin Drugs 0.000 claims description 8
- 229940087068 glyceryl caprylate Drugs 0.000 claims description 8
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 claims description 8
- 230000003750 conditioning effect Effects 0.000 claims description 7
- 229960004275 glycolic acid Drugs 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 241000207929 Scutellaria Species 0.000 claims description 5
- 229940059958 centella asiatica extract Drugs 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 229940084801 salvia miltiorrhiza root extract Drugs 0.000 claims description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 4
- 241000202807 Glycyrrhiza Species 0.000 claims description 4
- 238000007599 discharging Methods 0.000 claims description 4
- 235000013399 edible fruits Nutrition 0.000 claims description 4
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 claims description 4
- 238000011282 treatment Methods 0.000 claims description 3
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 2
- 241000908178 Tremella fuciformis Species 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 244000170916 Paeonia officinalis Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 48
- 231100000241 scar Toxicity 0.000 abstract description 8
- 208000032544 Cicatrix Diseases 0.000 abstract description 7
- 230000037387 scars Effects 0.000 abstract description 7
- 238000005562 fading Methods 0.000 abstract description 4
- 239000004909 Moisturizer Substances 0.000 abstract description 3
- 230000001333 moisturizer Effects 0.000 abstract description 3
- 244000236658 Paeonia lactiflora Species 0.000 abstract description 2
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract description 2
- 239000000686 essence Substances 0.000 description 54
- 210000003491 skin Anatomy 0.000 description 47
- 230000000052 comparative effect Effects 0.000 description 27
- 206010061218 Inflammation Diseases 0.000 description 16
- 238000012360 testing method Methods 0.000 description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 14
- 230000004054 inflammatory process Effects 0.000 description 12
- 230000001815 facial effect Effects 0.000 description 11
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 102000003425 Tyrosinase Human genes 0.000 description 9
- 108060008724 Tyrosinase Proteins 0.000 description 9
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 8
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 208000020154 Acnes Diseases 0.000 description 7
- 230000001804 emulsifying effect Effects 0.000 description 7
- 230000003020 moisturizing effect Effects 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 230000003213 activating effect Effects 0.000 description 6
- 230000003255 anti-acne Effects 0.000 description 6
- 230000003467 diminishing effect Effects 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000000419 plant extract Substances 0.000 description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- 241000186427 Cutibacterium acnes Species 0.000 description 5
- 230000032683 aging Effects 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 239000008055 phosphate buffer solution Substances 0.000 description 5
- 229940055019 propionibacterium acne Drugs 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- 229960004441 tyrosine Drugs 0.000 description 5
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 4
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 4
- 241000628997 Flos Species 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 229960000458 allantoin Drugs 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 208000031513 cyst Diseases 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- -1 polydimethylsiloxane Polymers 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 238000010998 test method Methods 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 3
- 206010033733 Papule Diseases 0.000 description 3
- 244000000231 Sesamum indicum Species 0.000 description 3
- 235000003434 Sesamum indicum Nutrition 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- 230000003385 bacteriostatic effect Effects 0.000 description 3
- 239000007765 cera alba Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000003780 hair follicle Anatomy 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 3
- 235000019799 monosodium phosphate Nutrition 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 238000011056 performance test Methods 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 229920000058 polyacrylate Polymers 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 229960004889 salicylic acid Drugs 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 230000009759 skin aging Effects 0.000 description 3
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 3
- 229940084750 sophora flavescens root extract Drugs 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- WVTKBKWTSCPRNU-KYJUHHDHSA-N (+)-Tetrandrine Chemical compound C([C@H]1C=2C=C(C(=CC=2CCN1C)OC)O1)C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@@H]2N(C)CCC3=CC(OC)=C(OC)C1=C23 WVTKBKWTSCPRNU-KYJUHHDHSA-N 0.000 description 2
- KZVAAIRBJJYZOW-VPENINKCSA-N (2r,3r,4s)-2-(hydroxymethyl)oxolane-3,4-diol Chemical compound OC[C@H]1OC[C@H](O)[C@H]1O KZVAAIRBJJYZOW-VPENINKCSA-N 0.000 description 2
- XFRVVPUIAFSTFO-UHFFFAOYSA-N 1-Tridecanol Chemical compound CCCCCCCCCCCCCO XFRVVPUIAFSTFO-UHFFFAOYSA-N 0.000 description 2
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- ILCOCZBHMDEIAI-UHFFFAOYSA-N 2-(2-octadecoxyethoxy)ethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCOCCO ILCOCZBHMDEIAI-UHFFFAOYSA-N 0.000 description 2
- OPJWPPVYCOPDCM-UHFFFAOYSA-N 2-ethylhexyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC OPJWPPVYCOPDCM-UHFFFAOYSA-N 0.000 description 2
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 description 2
- 229940099451 3-iodo-2-propynylbutylcarbamate Drugs 0.000 description 2
- WYVVKGNFXHOCQV-UHFFFAOYSA-N 3-iodoprop-2-yn-1-yl butylcarbamate Chemical compound CCCCNC(=O)OCC#CI WYVVKGNFXHOCQV-UHFFFAOYSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 241000167550 Centella Species 0.000 description 2
- 229920000832 Cutin Polymers 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 2
- BVTHRGZMQHOCOL-UHFFFAOYSA-N OCC(O)(C1(NC(=O)NCNC(=O)NC2(CO)NC(=O)NC2=O)NC(=O)NC1=O)CO Chemical compound OCC(O)(C1(NC(=O)NCNC(=O)NC2(CO)NC(=O)NC2=O)NC(=O)NC1=O)CO BVTHRGZMQHOCOL-UHFFFAOYSA-N 0.000 description 2
- 241000736199 Paeonia Species 0.000 description 2
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 206010037888 Rash pustular Diseases 0.000 description 2
- 206010039580 Scar Diseases 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- 229940083987 anhydroxylitol Drugs 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 2
- 229940075529 glyceryl stearate Drugs 0.000 description 2
- 229940084760 glycyrrhiza inflata root extract Drugs 0.000 description 2
- 229960003639 laurocapram Drugs 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 229940101267 panthenol Drugs 0.000 description 2
- 235000020957 pantothenol Nutrition 0.000 description 2
- 239000011619 pantothenol Substances 0.000 description 2
- 229940100460 peg-100 stearate Drugs 0.000 description 2
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 229960003415 propylparaben Drugs 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 208000029561 pustule Diseases 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 230000037394 skin elasticity Effects 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 238000011895 specific detection Methods 0.000 description 2
- 229940098760 steareth-2 Drugs 0.000 description 2
- 229940100458 steareth-21 Drugs 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 2
- 229940087291 tridecyl alcohol Drugs 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- YLRXAIKMLINXQY-ZDUSSCGKSA-O (S)-magnoflorine Chemical compound C1=C(OC)C(O)=C2C3=C(O)C(OC)=CC=C3C[C@@H]3[N+](C)(C)CCC1=C23 YLRXAIKMLINXQY-ZDUSSCGKSA-O 0.000 description 1
- CWVRJTMFETXNAD-GMZLATJGSA-N 5-Caffeoyl quinic acid Natural products O[C@H]1C[C@](O)(C[C@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-GMZLATJGSA-N 0.000 description 1
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 206010004950 Birth mark Diseases 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010008488 Glycylglycine Proteins 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 1
- KYEAXNAYHSCLMT-CVVGWEDFSA-N Magnoflorine Natural products C[C@H]1OC=C2[C@@H]3[C@@H]1CN4CCc5c([nH]c6ccccc56)[C@@H]4[C@@H]3OC2=O KYEAXNAYHSCLMT-CVVGWEDFSA-N 0.000 description 1
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- RBBVPNQTBKHOEQ-KKSFZXQISA-O Phellodendrine Chemical compound C1CC2=CC(OC)=C(O)C=C2[C@H]2[N@+]1(C)CC(C=C(C(=C1)O)OC)=C1C2 RBBVPNQTBKHOEQ-KKSFZXQISA-O 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 208000009077 Pigmented Nevus Diseases 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 240000007164 Salvia officinalis Species 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 241000519995 Stachys sylvatica Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- RECUKUPTGUEGMW-UHFFFAOYSA-N carvacrol Chemical compound CC(C)C1=CC=C(C)C(O)=C1 RECUKUPTGUEGMW-UHFFFAOYSA-N 0.000 description 1
- HHTWOMMSBMNRKP-UHFFFAOYSA-N carvacrol Natural products CC(=C)C1=CC=C(C)C(O)=C1 HHTWOMMSBMNRKP-UHFFFAOYSA-N 0.000 description 1
- 235000007746 carvacrol Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000014670 detection of bacterium Effects 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 238000002825 functional assay Methods 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 229940107131 ginseng root Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- WYXXLXHHWYNKJF-UHFFFAOYSA-N isocarvacrol Natural products CC(C)C1=CC=C(O)C(C)=C1 WYXXLXHHWYNKJF-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229930014456 matrine Natural products 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 239000002120 nanofilm Substances 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 1
- 229940084032 paeonia lactiflora root extract Drugs 0.000 description 1
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000003405 preventing effect Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- WVTKBKWTSCPRNU-UHFFFAOYSA-N rac-Tetrandrin Natural products O1C(C(=CC=2CCN3C)OC)=CC=2C3CC(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2CC2N(C)CCC3=CC(OC)=C(OC)C1=C23 WVTKBKWTSCPRNU-UHFFFAOYSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 244000132619 red sage Species 0.000 description 1
- 235000005412 red sage Nutrition 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009044 synergistic interaction Effects 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- CWVRJTMFETXNAD-NXLLHMKUSA-N trans-5-O-caffeoyl-D-quinic acid Chemical compound O[C@H]1[C@H](O)C[C@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-NXLLHMKUSA-N 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Botany (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cosmetics (AREA)
Abstract
The application relates to an acne-removing and mark-eliminating composition and application thereof, wherein the composition comprises the following raw materials: extracts of garcinia mangostana pericarp, salvia miltiorrhiza root, paeonia lactiflora root, honeysuckle flower, phellodendron amurense, thyme, sophora flavescens root, glycyrrhiza inflata root, scutellaria baicalensis root, centella asiatica, tremella, skin conditioners, moisturizers and solvents. The acne-removing and mark-eliminating composition can be added into essence and cream, and the addition amount of the acne-removing and mark-eliminating composition in the essence and the cream accounts for 6-8% of the total mass of the essence and the cream. The acne removing cream has the effects of improving the acne removing effect of an acne removing product and eliminating and fading the acne marks and scars.
Description
Technical Field
The application relates to the field of cosmetics, in particular to an acne and acne mark removing composition and application thereof.
Background
Acne, also known as acne vulgaris, is a chronic inflammation of the sebaceous glands of the hair follicle, usually occurring in the face, the chest and the shoulder blade. Light acnes are characteristic of the skin of most young people in the adolescent period, severe acnes are formed by excessive sebum secretion of the skin, hair follicle blockage, excessive reproduction of anaerobic propionibacterium acnes in hair follicles and accumulation of inflammatory substances, and pigmentation and skin tissue damage caused by inflammation of the severe acnes easily cause the problems of acne marks, pockmarks, scars and the like of the skin after the acne subsides.
Many acne-removing products sold in the market at present mainly have the main effects of sterilization and inflammation diminishing and are assisted by hormone components, so that on one hand, the tolerance of germs in the acne to the hormone is enhanced and the acne-removing effect is reduced by using the hormone by consumers for a long time; on the other hand, the skin is easily damaged by hormone, so that the skin is thin and sensitive.
Aiming at the related technical problems, the inventor considers that the existing acne removing product cannot rapidly and efficiently achieve the acne removing effect and is not ideal for the function of removing acne marks and scars.
Disclosure of Invention
In order to improve the acne removing effect of an acne removing product and the functions of eliminating acne marks and scars, the application provides an acne removing and acne mark eliminating composition and application thereof.
In a first aspect, the technical scheme of the acne and mark removing composition provided by the application is as follows:
the acne and mark removing composition comprises the following raw materials in percentage by mass:
0.22-0.42wt% of mangosteen pericarp extract;
0.04-0.08wt% of salvia miltiorrhiza root extract;
radix Paeoniae extract 1.02-1.12 wt%;
honeysuckle flower extract 0.04-0.08 wt%;
0.47-0.67wt% of phellodendron amurense extract;
0.47-0.67wt% of thyme extract;
0.33-0.53wt% of kuh-seng root extract;
0.33-0.53wt% of glycyrrhiza inflate extract;
0.47-0.67wt% of scutellaria root extract;
2.66-3.06wt% of centella asiatica extract;
4.19-4.39wt% of tremella extract;
3.04-3.24wt% of skin conditioner;
4.29 to 6.29 weight percent of humectant;
the solvent was added to 100 wt%.
By adopting the technical scheme, the phellodendron amurense extract contains various alkaloids such as berberine, magnoflorine, phellodendrine, tetrandrine and the like, and lactone, sterol, mucoid and the like, can promote the generation of collagen, and has the anti-aging effect by combining the oxidation resistance of the phellodendron amurense extract; the thyme extract mainly contains thymol, carvacrol, linalool, para-cymene and other compounds, and has skin-activating and anti-wrinkle effects due to the inhibition of elastase and collagenase; the cortex Phellodendri extract and herba Thymi extract can inhibit excessive sebum, open pore, control acne inflammation and improve oily skin acne;
the active ingredient of the sophora flavescens ait root extract is mainly matrine, has the effects of resisting bacteria and diminishing inflammation, has the effects of promoting the production of collagen and the proliferation of fibroblasts, and can be used for moisturizing and resisting aging of skin; the glycyrrhiza inflate extract has the effects of proliferating muscle cells, promoting the generation of collagen-4, improving the activity of skin, inhibiting melanin and whitening skin; has inhibiting effect on acne bacillus and Staphylococcus aureus, and can be used for killing bacteria and relieving inflammation of acne; the scutellaria root extract contains a large amount of amino acids and proteins, so that the skin aging can be well delayed, and the water replenishing and moisture preserving of the skin can be promoted; the common action of the sophora flavescens root extract, the glycyrrhiza inflate root extract and the scutellaria baicalensis root extract can play a better role in sterilizing and diminishing inflammation, so that acne can be quickly removed;
the garcinia mangostana pericarp extract has the effects of inhibiting tyrosinase, inhibiting melanin generation, slowing down collagen fiber degradation and maintaining skin elasticity; the salvia miltiorrhiza root extract has good promotion effect on the proliferation of collagen, can enhance the metabolism of the dermis of the skin, has good oxidation resistance, and can be used for activating the skin and resisting wrinkles; the radix Paeoniae extract contains paeoniflorin as effective component, which has effects of inhibiting pathogenic bacteria and fungi, and activating skin and resisting aging; caffeoylquinic acid contained in flos Lonicerae extract has strong antibacterial, fat reducing, skin caring and skin aging preventing effects, luteolin has antibacterial and antiinflammatory effects, has strong permeability to skin, can eliminate free radical, and has ultraviolet absorbing function; the four ingredients can be synergistic, and the effects of balancing skin grease, diminishing inflammation, inhibiting bacteria, repairing barriers, reducing acne mark generation and repairing severe depressed scars are achieved;
the centella asiatica extract can promote the production of collagen, enhance the skin elasticity, and also has the effects of tranquilizing and stabilizing, and improving the skin sensitivity; the tremella extract mainly contains tremella polysaccharide, so that the skin is smoother, the moisture can be kept efficiently, the skin aging is effectively resisted, the skin is tightened, and acne marks are reduced; the two have good moisture-keeping and activating effects under the combined action, and can promote the absorption of the effective components by the skin;
by adopting the combined action of the natural plant extracts, the humectant, the skin conditioner and other components, the acne removing and acne mark eliminating composition realizes a series of omnibearing acne removing and acne mark eliminating treatments of initially controlling oil, further sterilizing, then relieving and conditioning skin, resisting inflammation and removing acne, eliminating acne marks, cleaning skin, removing cutin and activating cell activity, finally has strong acne removing and acne mark eliminating effects, can reduce acne mark residues under the conditions of inhibiting melanin generation and promoting dermis cell repair, efficiently and quickly eliminates acne marks in a short time, repairs acne pits, and accordingly realizes long-term conditioning, tendering skin and whitening skin.
Preferably, the humectant comprises one or two of dehydrated xylitol and dehydrated xylitol.
By adopting the technical scheme, the anhydroxylitol and the xylitol have excellent moisturizing capability, glycerin can be replaced for use, the greasy and sticky feeling similar to glycerin does not exist, the anhydroxylitol and the xylitol are added into the composition, the moisturizing effect of the composition is favorably improved, the composition has cool and comfortable feeling when used, the red and swollen uncomfortable feeling of acne and the like is favorably relieved, the penetration of active ingredients in the composition to skin cells is accelerated, and the acne-removing and mark-eliminating effects are further improved.
Preferably, the humectant is prepared by mixing 79-82wt% of dehydrated xylitol, 13.2-13.7wt% of xylitol and the balance of 1, 2-hexanediol.
By adopting the technical scheme, the dehydrated xylitol and the xylitol are combined and compounded in a ratio of approximately 6:1, the ratio of the dehydrated xylitol and the xylitol is suitable for promoting the cooperation effect between the dehydrated xylitol and the xylitol to be more prominent, and the improvement of the permeation moisturizing performance and the acne and mark removing effect of the composition are reflected.
Preferably, the skin conditioning agent comprises glycolic acid, glyceryl caprylate and ethylhexyl glycerin, and the mass ratio of the glycolic acid to the glyceryl caprylate to the ethylhexyl glycerin is (20-22):1: 1.
By adopting the technical scheme, the glycolic acid is the tartaric acid with the minimum relative molecular mass, can effectively permeate pores, accelerate cell shedding, promote skin renewal, improve skin hyperkeratosis, loosen keratotic plugs blocking the pores and keep the pores smooth; glyceryl caprylate exhibits excellent anti-gram activity; ethylhexyl glycerin can improve the problem of dry skin, can make the skin look more moist; the glycolic acid, the ethylhexyl glycerin and the glyceryl caprylate are combined and compounded according to a specific proportion, so that a good skin conditioning effect can be achieved, the synergistic effect of various plant extracts in the composition can be enhanced, the composition can more efficiently remove acnes and inflammation, quickly remove acne marks and repair the skin.
Preferably, the solvent includes water, butylene glycol and propylene glycol.
By adopting the technical scheme, the garcinia mangostana fruit peel extract, the salvia miltiorrhiza root extract, the glycyrrhiza inflata root extract, the honeysuckle flower extract and the like can be well dissolved in water and propylene glycol; phellodendron amurense extract, thyme extract, sophora flavescens root extract, paeonia radix extract, scutellaria root extract, etc. are well dissolved in water and butylene glycol; the centella extract, the tremella extract, the skin activating agent and the preservative can be well blended into water and propylene glycol; compared with a single solvent, the selection of multiple solvents can more fully mix multiple different active ingredients in the composition, so that the composition system is more uniform and stable, and the performance of the composition is stable.
Preferably, the preparation method of the acne-removing and acne-mark-removing composition comprises the following steps:
s1, heating the solvent to 40-50 ℃, and uniformly stirring;
s2, adding extracts of fruit peel of fructus Rhododendri mollis, radix Salviae Miltiorrhizae, radix Paeoniae, flos Lonicerae, cortex Phellodendri, herba Thymi, radix Sophorae Flavescentis, radix Glycyrrhizae, radix Scutellariae, herba Centellae, and Tremella under stirring, and stirring to dissolve;
s3, adding a skin conditioner and a humectant, mixing uniformly, filtering and discharging to obtain the acne and acne mark removing composition.
By adopting the technical scheme, the solvent is heated up in advance, various plant extracts are added, the full dissolution and dispersion of the plant extracts in the solvent are facilitated, and finally, the skin conditioner, the humectant and the preservative are added, the system stability is facilitated to be adjusted, and the acne-removing and acne-eliminating composition with uniform and stable components is finally obtained.
In a second aspect, the application provides an application of the acne-removing and mark-removing composition, which adopts the following technical scheme:
an application of the acne-removing and mark-eliminating composition is that the acne-removing and mark-eliminating composition is added into essence and cream.
By adopting the technical scheme, the acne-removing and acne-mark-eliminating composition is added to the essence and the face cream, so that the essence and the face cream have excellent anti-inflammation and acne-removing effects on the basis of basic moisturizing and skin tendering, the acne-removing and acne-mark-eliminating composition can also generate a matching effect with other effective components in the essence and the face cream, and the functional effects of the essence and the face cream are further improved.
Preferably, the addition amount of the acne-removing and mark-eliminating composition in essence and cream accounts for 6-8% of the total mass of the essence and the cream.
By adopting the technical scheme, the addition amount of the acne-removing and acne-removing composition in the essence and the face cream is controlled in a proper range, so that the essence and the face cream can achieve a good anti-inflammation and acne-removing effect, the composition is better matched with other effective components in the essence and the face cream, the problems that the addition amount of the composition is small, the acne-removing effect is not obvious, or the excessive addition amount of the composition can inhibit other components are avoided, and the functional effects of the essence and the face cream are more prominent.
In summary, the present application includes at least one of the following beneficial technical effects:
1. according to the acne-removing and acne-eliminating composition, a series of omnibearing acne-removing treatments including preliminary oil control, further sterilization, skin soothing and conditioning, anti-inflammation and acne-removing, acne mark elimination, and final later-stage protection of skin cleaning, cutin removal and cell activity activation are realized by adopting the combined action of various natural plant extracts, the humectant and other components, so that the acne-removing and acne-eliminating composition has a strong acne-removing and anti-inflammation effect, can reduce the residue of the acne mark, quickly eliminate the acne mark, further improve the activity elasticity of the skin, whiten the skin and resist aging;
2. the moisture retention agent is prepared by mixing 79-82wt% of dehydrated xylitol, 13.2-13.72 wt% of xylitol and the balance of 1, 2-hexanediol; the dehydrated xylitol and xylitol have excellent moisturizing capability, can replace glycerin without greasy and sticky feeling similar to glycerin, and are added into the composition according to a specific proportion, so that the moisturizing effect of the composition is improved, the composition can bring cool and comfortable feeling to the skin when in use, and the red and swollen uncomfortable feeling of acne and the like is relieved;
3. the acne-removing and acne-removing mark-removing composition prepared by the method is added into the essence and the cream in an amount of 6% -8% of the total mass of the essence and the cream, and is favorable for better matching of the composition with other effective components in the essence and the cream, so that the essence and the cream achieve better effects of diminishing inflammation and removing acne.
Detailed Description
The present application will be described in further detail below with reference to preparation examples, comparative examples, application examples, and comparative application examples.
Preparation examples
Preparation example 1
The preparation example discloses a humectant, and the preparation method of the humectant comprises the following steps: 0.9kg of dehydrated xylitol and 0.1kg of 1, 2-hexanediol are added into a stirring pot, and stirred for 5min under the condition that the rotating speed is 100r/min, so as to obtain the humectant.
Preparation example 2
The preparation example discloses a humectant, and the preparation method of the humectant comprises the following steps: adding 0.96kg of xylitol and 0.04kg of 1, 2-hexanediol into a stirring pot, and stirring for 5min at the rotation speed of 100r/min to obtain the humectant.
Preparation example 3
The preparation example discloses a humectant, and the preparation method of the humectant comprises the following steps: 0.47kg of dehydrated xylitol, 0.47kg of xylitol and 0.06kg of 1, 2-hexanediol are added into a stirring pot, and stirred for 5min under the condition that the rotating speed is 100r/min to obtain the humectant.
Preparation example 4
The preparation example discloses a humectant, and the preparation method of the humectant comprises the following steps: 0.79kg of dehydrated xylitol, 0.132kg of xylitol and 0.078kg of 1, 2-hexanediol are added into a stirring pot, and stirred for 5min at the rotating speed of 100r/min to obtain the humectant.
Preparation example 5
The preparation example discloses a humectant, and the preparation method of the humectant comprises the following steps: 0.82kg of dehydrated xylitol, 0.137kg of xylitol and 0.043kg of 1, 2-hexanediol are added into a stirring pot, and stirred for 5min under the condition that the rotating speed is 100r/min to obtain the humectant.
Examples
Examples 1 to 5
Examples 1-5 disclose an acne and acne mark removing composition, which comprises the following raw materials: extracts of garcinia mangostana pericarp, salvia miltiorrhiza root, paeonia lactiflora root, honeysuckle flower, phellodendron amurense, thyme, sophora flavescens root, glycyrrhiza inflata root, scutellaria baicalensis root, centella asiatica, tremella, skin conditioners, moisturizers, butylene glycol, propylene glycol and water; wherein the humectant is one or two of dehydrated xylitol and xylitol; the skin conditioning agent comprises glycolic acid, glyceryl caprylate and ethylhexyl glycerin, wherein the mass ratio of the glycolic acid to the glyceryl caprylate to the ethylhexyl glycerin is 20:1: 1. (wherein the extracts of garcinia mangostana pericarp, the red sage root, the peony root, the honeysuckle flower, the phellodendron amurense and the thyme are all obtained from Guangzhou Galen Biotech Co., Ltd. with a water extraction ratio of 10: 1; the extracts of the bitter ginseng root, the swollen fruit licorice root, the Scutellaria root, the centella asiatica and the tremella are all obtained from Zhengzhou Koma Biotech Co., Ltd. with a water extraction ratio of 10: 1;)
Embodiments 1-5 also disclose a preparation method of the acne-removing and mark-removing composition, which specifically comprises the following steps:
s1, putting water, butanediol and propylene glycol into an emulsifying pot, heating to 40-50 ℃, and homogenizing and dispersing for 3min at the rotation speed of 300 r/min;
s2, adding the garcinia mangostana pericarp extract, the salvia miltiorrhiza root extract, the paeonia lactiflora root extract, the honeysuckle flower extract, the phellodendron amurense extract, the thyme extract, the sophora flavescens root extract, the glycyrrhiza inflata root extract, the scutellaria baicalensis root extract, the centella asiatica extract and the tremella extract into an emulsifying pot while stirring at the rotation speed of 200r/min, and homogenizing and dispersing for 15min at the rotation speed of 1000r/min to obtain a mixed solution;
s3, adding a skin conditioner and a humectant, and homogenizing and dispersing for 5min at the rotation speed of 1000 r/min; and then filtering the mixed solution by adopting a 100-mesh nano-film to obtain the acne and acne mark removing composition.
Examples 1-3 the amounts (kg) of the above-mentioned raw materials and the temperature parameters (. degree. C.) in the preparation of the compositions are specifically shown in Table 1.
TABLE 1
Comparative example
Comparative example 1
A method for preparing a composition for removing acne and marks, which is different from the method in example 3 in that: replacing extracts of pericarp of fructus Rhododendri mollis, radix Salviae Miltiorrhizae, radix Paeoniae, and flos Lonicerae with equal amount of cacumen Platycladi extract.
Comparative example 2
A method for preparing a composition for removing acne and marks, which is different from the method in example 3 in that: replacing cortex Phellodendri extract and herba Thymi extract with equal amount of herba Taraxaci extract.
Comparative example 3
The preparation method of the acne-removing and mark-eliminating composition is different from that of the embodiment 3 in that: replacing radix Sophorae Flavescentis extract, radix Glycyrrhizae Inflatae extract, and radix Scutellariae extract with fructus Cnidii extract.
Comparative example 4
The preparation method of the acne-removing and mark-eliminating composition is different from that of the embodiment 3 in that: the centella extract and the tremella extract are replaced by the aloe extract with the same quantity.
Application example
Application example 1
The application example discloses acne removing essence containing an acne removing and acne mark removing composition, which comprises the following components in parts by mass:
82.1kg of water, 4kg of methyl propylene glycol, 0.5kg of p-hydroxyacetophenone, 0.25kg of xanthan gum, 0.15kg of allantoin, 1.5kg of betaine, 1.05kg of salicylic acid, 1.35kg of dextrin, 0.6kg of sesame amino acids, 2kg of potassium azelaiyl diglycoate, 0.5kg of 1, 2-hexanediol and 6kg of acne-removing and mark-removing composition; the composition prepared in example 1 was used as the composition. (wherein salicylic acid, dextrin, sesame amino acids, potassium azeloyl diglycine are all purchased from Zhengzhou Koma Biotechnology Co., Ltd.)
The application example also discloses a preparation method of the acne removing essence, which comprises the following steps:
step 1, mixing water, methyl propylene glycol, p-hydroxyacetophenone, xanthan gum, allantoin and betaine, putting the mixture into a stirring pot, stirring at the speed of 1200r/min for 7min, heating to 85 ℃, and keeping the temperature for 20 min;
step 2, cooling to 40 ℃, adding salicylic acid, dextrin, sesame amino acids, potassium nonanedioyl diglycoate, 1, 2-hexanediol and the acne and acne removing composition into a stirring pot, stirring at the speed of 800r/min for 10min, filtering after the board is qualified, and discharging; aging for 24h to obtain the acne removing essence.
Application example 2
The application example discloses acne removing essence containing an acne and acne mark removing composition, and is different from the application example 1 in that: the acne removing essence contains 8kg of acne removing and acne mark removing composition and 80.1kg of water.
Application example 3
The application example discloses acne removing essence containing an acne and acne mark removing composition, and is different from the application example 1 in that: the acne removing essence contains 7kg of acne removing and acne mark removing composition and 81.1kg of water.
Application examples 4 to 7
Application examples 4 to 7 disclose an acne-removing essence containing an acne-removing and acne-mark-removing composition, which is different from application example 1 in that: the compositions for removing acne and acne marks contained in the acne-removing essence respectively correspond to the compositions prepared in the embodiments 2-5.
Application example 8
The application example discloses acne-removing cream containing an acne-removing and acne mark-removing composition, which comprises the following components in parts by mass:
58.kg of water, 4kg of glycerol, 1.65kg of cyclopentasiloxane, 3.35kg of cyclohexasiloxane, 3kg of polydimethylsiloxane, 22.5 kg of steareth-212.5 kg of steareth, 2kg of white beeswax, 2kg of ethylhexyl palmitate, 2kg of cetearyl alcohol, 2kg of caprylic/capric triglyceride, 0.75kg of glyceryl stearate, 0.75kg of PEG-100 stearate, 1kg of panthenol and 0.8kg of tocopherol acetate, 0.434kg of sodium polyacrylate, 0.238kg of ethylhexyl stearate, 60.028kg of tridecyl alcohol polyether, 0.5kg of laurocapram, 0.12kg of bis (hydroxymethyl) imidazolidinyl urea, 0.00135kg of iodopropynyl butylcarbamate, 0.17865kg of propylene glycol, 60.25 kg of polyacrylate cross-linked polymer, 0.25kg of allantoin, 0.2kg of methylparaben, 0.15kg of disodium EDTA, 0.1kg of propylparaben, 0.05kg of sodium hyaluronate and 7kg of acne-removing and acne-eliminating composition; the composition prepared in example 1 was used as the composition. (wherein Cyclopenta-dimethyl siloxane, cyclohexasiloxane, polydimethylsiloxane are available from Town (Zhang harbor) invest Ltd.; Steareth-2, Steareth-21 are available from Croda Singapore Pte Ltd.; white beeswax is available from Wachs-u.Cerein-Fabriken TH.C.TROMM GmbH; polyacrylate crosspolymer-6 is available from SEPPIC S.A.)
The application example also discloses a preparation method of the acne removing cream, which comprises the following steps:
step 1, adding water, glycerol, panthenol, polyacrylate cross-linked polymer-6, allantoin, methylparaben, EDTA disodium and sodium hyaluronate into a milk pot, stirring at the speed of 1200r/min for 5min, heating to 85 ℃, and preserving heat for 20 min;
step 2, adding cyclopentadimethylsiloxane, cyclohexasiloxane, polydimethylsiloxane, steareth-2, steareth-21, white beeswax, ethylhexyl palmitate, cetostearyl alcohol, caprylic/capric triglyceride, glyceryl stearate, PEG-100 stearate, tocopheryl acetate, laurocapram and propylhydroxybenzoate into an oil pan, stirring at the speed of 200r/min for 10min, heating to 85 ℃, and keeping the temperature for 20 min;
step 3, vacuumizing the emulsifying pot to-0.08 MPa, completely pumping the water phase into the emulsifying pot, completely pumping the oil phase into the emulsifying pot, homogenizing at 1000r/min for 3 minutes, and keeping the temperature for 25 minutes;
step 4, cooling to 75 ℃, adding the sodium polyacrylate, the ethylhexyl stearate and the tridecyl alcohol polyether-6 into an emulsifying pot, and homogenizing for 3min in vacuum at 1000 r/min;
and 5, cooling to 40 ℃, sequentially adding the bis (hydroxymethyl) imidazolidinyl urea, the iodopropynyl butylcarbamate, the propylene glycol and the acne and acne removing composition into an emulsifying pot, stirring at the speed of 200r/min for 10min, filtering and discharging after the plate is qualified, and aging the material body for 24h to obtain the acne removing cream.
Comparative application example
Comparative application examples 1 to 4
An acne removing essence containing an acne removing and acne mark removing composition is different from the application example 3 in that: the compositions for removing acnes and marks in the acne-removing essence are prepared in comparative examples 1-4 correspondingly.
Comparative application example 5
An acne removing essence containing an acne removing and acne mark removing composition is different from the application example 3 in that: the acne-removing and acne-mark-removing composition is not added in the acne-removing essence.
Comparative example
A commercially available acne-removing essence.
Performance test
Experiment one: and (3) detecting the performances of the acne-removing and mark-eliminating composition:
1. and (3) sterilization performance detection:
1.1 detection of bacteria: propionibacterium acnes, which is the main pathogenic bacterium causing acne.
1.2 Standard: refer to GB15979-2002 "hygienic Standard for Disposable sanitary articles" appendix C4 "test method for antibacterial property of dissoluble antibacterial product".
1.3. The specific detection test method comprises the following steps:
1) test samples: the compositions described in examples 1-5 and comparative examples 1-4 were diluted to 2% dilutions, respectively;
2) preparation of bacterial suspension: washing a 24-hour culture of the propionibacterium acnes by using 0.03mol/L phosphate buffer solution to prepare 104-106CFU/mL bacterial suspension;
3) respectively taking 1g of test sample, adding 0.1mL of the bacterial suspension, uniformly coating and mixing, starting timing, adding 9mL of 0.03mol/L phosphate buffer solution after 20min, fully and uniformly mixing, taking 3 dilutions, respectively taking 1mL of the dilutions, placing the dilutions in two parallel plates, adding corresponding culture medium, and culturing for 24 hours at 36 +/-1 ℃ under anaerobic condition to count bacterial colonies. Repeating the test for 3 times, taking the average number, and setting a blank control group;
the calculation formula of the bacteriostatic rate is as follows: x is (A-B)/A X100%, wherein X is the bacteriostasis rate, A is the average recovered colony of a blank control sample, and B is the average recovered colony of a test sample; the specific results are shown in Table 3.
1.4. The evaluation criteria for efficacy were: (1) the effect is obvious when the bacteriostasis rate is more than or equal to 90 percent; (2) the bacteriostatic rate is 40-90% and the effect is normal; (3) the bacteriostasis rate is less than 40 percent, which indicates no effect.
2. Tyrosinase activity inhibition assay:
2.1 reagent: tyrosinase, tyrosine, sodium dihydrogen phosphate, disodium hydrogen phosphate, a positive control (arbutin powder), a sample and deionized water;
2.2 reagent preparation:
2.2.1, phosphate buffer (PH 6.8):
0.2M sodium dihydrogen phosphate: weighing 71.6g of Na2HPO4-12H2O, and dissolving in 1000ml of deionized water;
0.2M disodium hydrogen phosphate: weighing 31.2g of NaH2PO4-2H2O, and dissolving in 1000ml of deionized water;
the phosphate buffer solution with 0.2M, PH ═ 6.8 was prepared by taking 51ML sodium dihydrogen phosphate and 49ML disodium hydrogen phosphate.
2.2.2, L-tyrosine solution: weighing 25.6g of L-tyrosine, and using phosphate buffer solution to be dissolved in a 50mL volumetric flask to obtain the L-tyrosine solution.
2.2.3, tyrosinase solution: cleaning potato, and precooling at 4 deg.C for about 4 h. Peeling, and cutting into about 1.0cm 3 D-form, and freeze at-20 ℃ overnight. Weighing according to the weight ratio of 1: 1(W: V), adding a 4 ℃ pre-cooled sodium phosphate buffer solution, preparing into homogenate by using a tissue triturator, filtering by using 3 layers of gauze, centrifuging the filtrate at 4000r/min for 10min, and storing the supernatant, namely the obtained tyrosinase crude enzyme solution, at 4 ℃ and using up the tyrosinase crude enzyme solution within 2 h.
2.2.4, preparation of test solution: the acne and acne mark removing compositions prepared in examples 1 to 5 and comparative examples 1 to 4 of the application are respectively diluted to 1mg/ml by methanol.
2.2.5, positive control: dissolving 0.01g of arbutin powder in 10ml of methanol solution to obtain 1mg/ml reference substance solution.
2.3 test methods:
the phosphate buffer solution, the sample solution, and the tyrosine solution were added to the test tube in the order shown in the following table, and water bath was carried out at 35 ℃ for 10 minutes. Adding tyrosinase solution, mixing, incubating at 35 deg.C for 30min, quickly transferring to a cuvette, and measuring absorbance at 475nm
The test is carried out, the total reaction system of each group of tests is 5mL, and the specific design is shown in Table 2:
TABLE 2-5 mL test System design
The blank control group 1 is used for zeroing the tested group, the blank control group 2 is used for zeroing the negative control group, and the blank control group 3 is used for zeroing the positive control group;
the absorbance of the test group is A1, the absorbance of the negative control group is A2, and the absorbance of the positive control group is A3.
Inhibition rate ═ 1- [ (a1-a 2)/(A3-a 2) ] × 100% — (A3-a1)/(A3-a2) × 100%; specific results are shown in Table 3.
Experiment two: and (3) detecting the efficacy of the acne removing essence finished product:
1. subject: selecting 140 male and female half subjects for testing, and dividing the subjects into 14 groups of 10 subjects, wherein the ratio of male to female in each group is 1: 1; the subjects are required to have no allergic history of skin diseases, no influence factors such as birthmarks, scratch marks, white spots, pigmented nevi and the like on the facial skin, and no anti-inflammatory drugs and the like are used on the tested parts within two months; the subjects showed pimples on the forehead, cheeks and chin, mostly black and white, pink and red acne, pimples or cyst on the top, itching or pain; the face of the subject dispersed acne marks and scars (which were generated within one month).
2. The test substance: the test products are the acne removal essence prepared by application examples 1-8, comparative application examples 1-5 and comparative examples.
3. Experimental comparison standards: subject self-ante-post controls and interclass parallel controls were used.
4. Detecting items: detecting the acne removing rate; detecting the acne scar eliminating time:
5. the specific detection test method comprises the following steps: the subjects of 12 groups respectively use the acne removal essences prepared in application examples 1-7 and comparative application examples 1-5, the rest two groups use the acne removal essence milk prepared in comparative example, and the other group use the acne removal cream prepared in application example 8; the using method comprises the following steps: the anti-acne essence (anti-acne cream) is used by a subject in the morning and at night after face cleaning, the using amount of the anti-acne essence is 0.5 g/time (0.2 g/time) and the anti-acne essence is smeared on the face and is gently massaged until the anti-acne essence is absorbed. The product usage period was 30 days, facial conditions of subjects before and for 3, 7, 15 and 30 days using the product were photographed by a skin facial analyzer visiac (Canfield, usa) and facial Image analysis software Image-Pro Plus (Media Cybernetics, Inc.) respectively, and symptoms were recorded; calculating the decrement of the number of inflammatory papules or pustules of the average population of the subject to obtain the acne removal rate; recording the situation of the face acne marks, scars and pockmarks of the subject with reduced dissipation area to obtain dissipation rate; taking the average value of each group; the specific test records are detailed in tables 4 and 5.
The specific data of the performance testing experiments are detailed in tables 3-5.
TABLE 3 functional assay of the compositions
TABLE 4 acne-removing essence facial condition recording sheet
TABLE 5 functional detection data of acne-removing essence
The comparison of the performance test data for examples 1-5 and comparative examples 1-4 in Table 3 can be seen: the anti-acne and mark-removing composition prepared in the examples 1-5 has a bacteriostatic rate of more than 95% on propionibacterium acnes, which shows that the composition has a good bactericidal and anti-inflammatory effect; the inhibition rate of the composition on tyrosinase activity is more than 88%, which shows that the composition can fully inhibit the generation of skin melanin, further reduce the generation of acne marks and fade the acne marks.
Comparative examples 1-4 show extracts of pericarp of mangosteen, radix Salviae Miltiorrhizae, radix Paeoniae, and flos Lonicerae, respectively, in the composition; phellodendron amurense extract, thyme extract; radix Sophorae Flavescentis extract, radix Glycyrrhizae Inflatae extract, and radix Scutellariae extract; the centella asiatica extract and the tremella fuciformis extract are replaced, the replaced substances have similar functional effects with the substances, but the substances after replacement are difficult to generate the synergistic interaction effect among the substances, so that the composition prepared in the comparative examples 1-4 has the advantages of reducing the bacteriostasis rate of propionibacterium acnes and the inhibition rate of tyrosinase activity, and is difficult to exert the effects of removing acne and diminishing inflammation, inhibiting melanin generation and fading acne marks.
The performance test data according to application examples 1 to 7 and the comparative example in tables 4 and 5 can be obtained: application examples 1 to 7 are that the acne and acne mark removing composition prepared in the examples 1 to 5 is applied to acne removing essence, wherein the addition amount of the composition in the essences in the application examples 1 to 3 is 6 to 8 percent, and the compositions prepared in the examples 2 and 3 are used in the application examples 4 and 5; after the test subject uses the acne removing essence prepared by the application examples 1-5 for 3 days, the dissipation rate of facial acne marks and pits reaches 1 percent, facial acnes and papules are not increased any more, and pustules and cysts begin to darken and shrink; the use of the acne removing essence for 3 days shows that the acne removing essence has already been effective and has quick response; the dissipation rate reaches nearly 80% after 15d, comedones and inflammatory papules are removed, nodules and cysts are mostly removed, and only a small amount of red acne marks exist; the acne removing essence can efficiently remove acnes and diminish inflammation, and has an obvious effect of fading and repairing acne marks and pits; application examples 6 and 7 used the compositions prepared in examples 4 and 5, wherein the moisturizer was further adjusted; the 3d dissipation rate of the acne removing essence prepared by the application examples 6 and 7 used by a subject reaches more than 1.5 percent, the 30d dissipation rate reaches more than 90 percent, facial acne nodules and cysts are basically eliminated, large acne marks are basically eliminated, and pit acne scars are obviously removed; the efficacy of the acne removing essence is further improved; the control case is a commercial acne removal essence, the effect of the test subject is started only by using the acne removal essence 7d of the control case, the dissipation rate is only 40% by using 30d, the effect of 15d used in application examples 1-7 of the application cannot be achieved, and the acne removal and repair effects on acne marks and pits are basically not achieved. The comparison of the data of the application examples 1-7 and the comparative example also obviously reflects that the acne removing essence has the remarkable effects of removing acne and acne marks, quickly removing acne marks and repairing pockmarks.
In comparative application examples 1 to 5, the acne-removing and acne-eliminating composition is not contained in the acne-removing essence prepared in comparative application example 5, and data shows that the basic components in the essence can not be used for better improving the facial acne condition; compared with the acne removing essence of application examples 1-4, the acne removing and acne mark eliminating composition prepared in the comparative examples 1-4 is respectively and correspondingly used, and due to the fact that various plant extracts in the composition are replaced, the replaced components are difficult to cooperate with each other in a synergistic mode, so that a subject can have a visual effect after using the acne removing essence of the comparative application examples 1-4 for 7 days, and the acne removing condition of facial acne and fading and repairing of acne marks, acne pits and acne scars after using the acne removing essence for 30 days are not obvious.
Application example 8 is to apply the composition prepared in example 1 to an acne-removing cream, and a subject starts to take effect when using the acne-removing cream prepared in application example 8 for 3 days, facial acne basically disappears after 15 days, and acne-removing and acne mark-dissipating effects are obvious after 30 days.
The above embodiments are preferred embodiments of the present application, and the protection scope of the present application is not limited by the above embodiments, so: all equivalent changes made according to the structure, shape and principle of the present application shall be covered by the protection scope of the present application.
Claims (8)
1. The acne and mark removing composition is characterized in that: the material comprises the following raw materials in percentage by mass:
0.22-0.42wt% of mangosteen pericarp extract;
0.04-0.08wt% of salvia miltiorrhiza root extract;
radix Paeoniae extract 1.02-1.12 wt%;
honeysuckle flower extract 0.04-0.08 wt%;
0.47-0.67wt% of phellodendron amurense extract;
0.47-0.67wt% of thyme extract;
0.33-0.53wt% of kuh-seng root extract;
0.33-0.53wt% of glycyrrhiza inflate extract;
0.47-0.67wt% of scutellaria root extract;
2.66-3.06wt% of centella asiatica extract;
4.19-4.39wt% of tremella extract;
3.04-3.24wt% of skin conditioner;
4.29 to 6.29 weight percent of humectant;
the solvent was added to 100 wt%.
2. The composition for removing acne and marks according to claim 1, which is characterized in that: the humectant comprises one or two of dehydrated xylitol and xylitol.
3. The composition for removing acne and marks according to claim 2, which is characterized in that: the humectant is prepared by mixing 79-82wt% of dehydrated xylitol, 13.2-13.7wt% of xylitol and the balance of 1, 2-hexanediol.
4. The composition for removing acne and eliminating acne marks according to claim 1, which is characterized in that: the skin conditioning agent comprises glycolic acid, glyceryl caprylate and ethylhexyl glycerin, wherein the mass ratio of the glycolic acid to the glyceryl caprylate to the ethylhexyl glycerin is (20-22) to 1: 1.
5. The composition for removing acne and eliminating acne marks according to claim 1, which is characterized in that: the solvent includes water, butylene glycol and propylene glycol.
6. The composition for removing acne and marks according to any one of claims 1,2, 4 and 5, wherein: the preparation method of the acne-removing and mark-eliminating composition comprises the following steps:
s1, heating the solvent to 40-50 ℃, and uniformly stirring;
s2, adding the extracts of the pericarp of the inverted twist fruit, the root of the salvia miltiorrhiza, the root of the peony, the honeysuckle, the phellodendron amurense, the thyme, the root of the sophora flavescens, the root of the glycyrrhiza inflata, the root of the scutellaria baicalensis, the centella asiatica and the tremella fuciformis under stirring, and uniformly stirring and dissolving;
s3, adding a skin conditioner and a humectant, uniformly mixing, filtering and discharging to obtain the acne-removing and acne-eliminating composition.
7. Use of a composition according to any one of claims 1 to 6 for the treatment of acne and acne marks, wherein: the acne-removing and mark-eliminating composition is added into essence and cream.
8. The use of the composition for removing acne and eliminating acne marks according to claim 7, wherein: the addition amount of the acne-removing and mark-eliminating composition in essence and cream accounts for 6-8% of the total mass of the essence and the cream.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210906071.2A CN115025024B (en) | 2022-07-29 | 2022-07-29 | Acne and mark removing composition and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210906071.2A CN115025024B (en) | 2022-07-29 | 2022-07-29 | Acne and mark removing composition and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN115025024A true CN115025024A (en) | 2022-09-09 |
| CN115025024B CN115025024B (en) | 2023-11-03 |
Family
ID=83130345
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210906071.2A Active CN115025024B (en) | 2022-07-29 | 2022-07-29 | Acne and mark removing composition and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115025024B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115778877A (en) * | 2022-12-19 | 2023-03-14 | 北京同仁堂麦尔海生物技术有限公司 | Acne removing composition |
| CN116869886A (en) * | 2023-07-27 | 2023-10-13 | 广州市精锐生物研究有限公司 | Acne-removing composition, and preparation method and application thereof |
| CN117752565A (en) * | 2023-12-18 | 2024-03-26 | 广州她她生物科技有限公司 | Acne-removing essence and preparation method thereof |
Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004269448A (en) * | 2003-03-11 | 2004-09-30 | Ichimaru Pharcos Co Ltd | Composition for cosmetic/health |
| JP2005281224A (en) * | 2004-03-30 | 2005-10-13 | Unitika Ltd | Skin-whitening agent |
| CN107595691A (en) * | 2017-09-01 | 2018-01-19 | 杨仁荷 | Acne eliminating cream and preparation method thereof |
| CN107920980A (en) * | 2015-09-21 | 2018-04-17 | 庆尚大学校产学协力团 | Contain the skin-whitening composition of β mangostins as active ingredient |
| CN108553376A (en) * | 2018-07-20 | 2018-09-21 | 佛山市秸和科技有限公司 | A kind of pox-eliminating whitening cream and preparation method thereof |
| CN108721156A (en) * | 2017-04-20 | 2018-11-02 | 广州市阿西娜化妆品制造有限公司 | A kind of plant composition and preparation method thereof |
| CN108969429A (en) * | 2018-10-16 | 2018-12-11 | 广州科玛生物科技股份有限公司 | A kind of anti-acne essence |
| CN109157450A (en) * | 2018-10-16 | 2019-01-08 | 广州科玛生物科技股份有限公司 | A kind of anti-acne essence cream |
| CN110664640A (en) * | 2019-10-17 | 2020-01-10 | 张军 | Plant essence whitening and acne removing essence and preparation method thereof |
| CN112516034A (en) * | 2020-12-21 | 2021-03-19 | 广州旭帆生物科技有限公司 | Plant acne removing agent and preparation method and application thereof |
| CN113750015A (en) * | 2021-10-20 | 2021-12-07 | 四川创臻科技有限公司 | Acne removing composition with acne mark removing and scar removing effects and preparation method thereof |
-
2022
- 2022-07-29 CN CN202210906071.2A patent/CN115025024B/en active Active
Patent Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004269448A (en) * | 2003-03-11 | 2004-09-30 | Ichimaru Pharcos Co Ltd | Composition for cosmetic/health |
| JP2005281224A (en) * | 2004-03-30 | 2005-10-13 | Unitika Ltd | Skin-whitening agent |
| CN107920980A (en) * | 2015-09-21 | 2018-04-17 | 庆尚大学校产学协力团 | Contain the skin-whitening composition of β mangostins as active ingredient |
| CN108721156A (en) * | 2017-04-20 | 2018-11-02 | 广州市阿西娜化妆品制造有限公司 | A kind of plant composition and preparation method thereof |
| CN107595691A (en) * | 2017-09-01 | 2018-01-19 | 杨仁荷 | Acne eliminating cream and preparation method thereof |
| CN108553376A (en) * | 2018-07-20 | 2018-09-21 | 佛山市秸和科技有限公司 | A kind of pox-eliminating whitening cream and preparation method thereof |
| CN108969429A (en) * | 2018-10-16 | 2018-12-11 | 广州科玛生物科技股份有限公司 | A kind of anti-acne essence |
| CN109157450A (en) * | 2018-10-16 | 2019-01-08 | 广州科玛生物科技股份有限公司 | A kind of anti-acne essence cream |
| CN110664640A (en) * | 2019-10-17 | 2020-01-10 | 张军 | Plant essence whitening and acne removing essence and preparation method thereof |
| CN112516034A (en) * | 2020-12-21 | 2021-03-19 | 广州旭帆生物科技有限公司 | Plant acne removing agent and preparation method and application thereof |
| CN113750015A (en) * | 2021-10-20 | 2021-12-07 | 四川创臻科技有限公司 | Acne removing composition with acne mark removing and scar removing effects and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 广州臻颜化妆品有限公司: ""MENGYAN檬颜精粹精华霜"", 《国产非特殊用途化妆品备案平台》, pages 1 - 2 * |
| 陈文良等: ""热带植物山竹在美容护肤领域应用的研究进展"", 《农产品加工》, no. 11, pages 136 - 79 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115778877A (en) * | 2022-12-19 | 2023-03-14 | 北京同仁堂麦尔海生物技术有限公司 | Acne removing composition |
| CN116869886A (en) * | 2023-07-27 | 2023-10-13 | 广州市精锐生物研究有限公司 | Acne-removing composition, and preparation method and application thereof |
| CN116869886B (en) * | 2023-07-27 | 2024-04-02 | 广州市精锐生物研究有限公司 | Acne-removing composition, and preparation method and application thereof |
| CN117752565A (en) * | 2023-12-18 | 2024-03-26 | 广州她她生物科技有限公司 | Acne-removing essence and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN115025024B (en) | 2023-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110522658B (en) | Anti-allergy repairing composition and preparation method thereof | |
| CN115025024B (en) | Acne and mark removing composition and application thereof | |
| CN108969446B (en) | Infant anti-chap skin care composition for enhancing skin barrier function and preparation method thereof | |
| CN109568215B (en) | Moisturizing and moisturizing repair essence cream containing soluble beeswax and preparation method thereof | |
| CN107550775B (en) | Natural plant anti-acne gel and preparation method thereof | |
| CN113750015B (en) | Acne-removing composition with acne mark and acne scar removing effects and preparation method thereof | |
| CN103142456B (en) | Traditional Chinese medicine acne removing face cream | |
| CN113197836A (en) | Moisturizing, relieving, itching-relieving and skin-protecting cream and preparation method thereof | |
| CN112641856B (en) | Anti-aging traditional Chinese medicine composition | |
| CN106177100B (en) | Composition with acne removing effect and application thereof | |
| CN112043661B (en) | Whitening aloe gel and preparation method thereof | |
| CN112426390A (en) | Natural traditional Chinese medicine acne-removing composition and preparation method thereof | |
| CN111228207B (en) | Dampness-rash-eliminating hip-protecting cream and preparation method thereof | |
| CN111249195B (en) | Refreshing astringent lotion and preparation method thereof | |
| CN113693979A (en) | Oil-control acne-removing composition and application thereof | |
| CN112426398A (en) | Acne removing composition with acne mark removing effect and preparation method thereof | |
| CN111529450A (en) | Deep moisturizing repair composition, skin care product and preparation method thereof | |
| WO2021203648A1 (en) | Traditional chinese medicine composition for preventing gingival atrophy and/or treating gingivitis | |
| CN112137904A (en) | Colorful water-light-skin-bottom essence and preparation method thereof | |
| CN112516066B (en) | Oil control composition and application thereof in cosmetics | |
| CN117338691A (en) | Oil control composition and preparation method thereof | |
| KR101034405B1 (en) | Antibiotic composition containing herbal medicine extracts | |
| CN115414308A (en) | Acne removing composition as well as preparation method and application thereof | |
| CN113749971A (en) | Skin care formula with anti-aging, whitening, moisturizing and skin care functions and preparation method thereof | |
| CN110856708A (en) | Facial mask liquid and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |